C12N 2799/023
Where the vector is derived from a poxvirus
Official title: where the vector is derived from a poxvirus
C12N2799/023 (Where the vector is derived from a poxvirus) appears on 146 US grants and 101 published applications in this corpus.
Search patents in C12N- Granted patents
- 146
- Published applications
- 101
- Assignees
- 84
- Inventors
- 212
- Latest grant
- 26 Nov 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 10 | 0 |
| 1999 | 16 | 0 |
| 2000 | 9 | 0 |
| 2001 | 10 | 2 |
| 2002 | 11 | 6 |
| 2003 | 9 | 13 |
| 2004 | 2 | 11 |
| 2005 | 5 | 10 |
| 2006 | 10 | 3 |
| 2007 | 2 | 4 |
| 2008 | 3 | 5 |
| 2009 | 6 | 6 |
| 2010 | 7 | 5 |
| 2011 | 4 | 7 |
| 2012 | 5 | 5 |
| 2013 | 3 | 2 |
| 2014 | 5 | 2 |
| 2015 | 5 | 4 |
| 2016 | 1 | 1 |
| 2017 | 2 | 5 |
| 2018 | 2 | 1 |
| 2019 | 3 | 5 |
| 2020 | 3 | 2 |
| 2021 | 2 | 1 |
| 2022 | 1 | 0 |
| 2023 | 2 | 1 |
| 2024 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- MVA vaccine for delivery of a UL128 complex and preventing CMV infection26 Nov 2024US 12,150,987 B2City of Hope
- Oncolytic virus for expression of immune checkpoint modulators10 Oct 2023US 11,779,619 B2Transgene S. A.
- MVA vaccine for delivery of a UL128 complex and preventing CMV infection8 Aug 2023US 11,717,568 B2City of Hope
- Immunostimulatory compositions and uses therefor29 Mar 2022US 11,285,191 B2Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Means and methods for treating HBV9 Feb 2021US 10,912,827 B2Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- Mva vaccine for delivery of a ul128 complex and preventing cmv infection14 Dec 2023US 2023/0398209 A1City of Hope
- Mva vaccine for delivery of a ul128 complex and preventing cmv infection17 Jun 2021US 2021/0177962 A1City of Hope
- Oncolytic virus for expression of immune checkpoint modulators25 Jun 2020US 2020/0197457 A1Transgene S. A.
- Mva vaccine for delivery of a ul128 complex and preventing cmv infection5 Mar 2020US 2020/0069791 A1City of Hope
- Immunostimulatory compositions and uses therefor7 Nov 2019US 2019/0336581 A1Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Most cited
By later US patents
- Redirection of cellular immunity by receptor chimeras135US 7,049,136 B2The General Hospital Corporation · 2006
- Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells108US 5,851,828 AThe General Hospital Corporation · 1998
- Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells106US 6,753,162 B1The General Hospital Corporation · 2004
- Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells99US 6,284,240 B1The General Hospital Corporation · 2001
- Chicken interleukin-15 and uses thereof88US 6,737,522 B2Wayne State University · 2004